A promising strategy against SARS-CoV-2: pyrimidine inhibitors synergize with nucleoside analogues

被引：6
|
作者：
Min, Long [1 ,2 ]
Sun, Qiu [1 ,2 ]
机构：
[1] Sichuan Univ, West China Hosp, Canc Ctr, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
[2] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2022年 / 7卷 / 01期
关键词：
D O I：
10.1038/s41392-022-00956-6
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Screening for inhibitors against SARS-CoV-2 and its variants
    Yuan, Weijing
    Dong, Xiaojing
    Chen, Lan
    Lei, Xiaobo
    Zhou, Zhuo
    Guo, Li
    Wang, Jianwei
    BIOSAFETY AND HEALTH, 2022, 4 (03) : 186 - 192
  • [32] Polymeric Materials as Potential Inhibitors Against SARS-CoV-2
    Umar, Yunusa
    Al-Batty, Sirhan
    Rahman, Habibur
    Ashwaq, Omar
    Sarief, Abdulla
    Sadique, Zakariya
    Sreekumar, P. A.
    Haque, S. K. Manirul
    JOURNAL OF POLYMERS AND THE ENVIRONMENT, 2022, 30 (04) : 1244 - 1263
  • [33] Targeting SARS-CoV-2 Main Protease (MPro) with Kinase Inhibitors: A Promising Approach for Discovering Antiviral and Anti-inflammatory Molecules against SARS-CoV-2
    Anton, Debora Bublitz
    Pedreira, Julia Galvez Bulhoes
    Zvirtes, Maria Luiza
    Laufer, Stefan A.
    Ducati, Rodrigo Gay
    Goettert, Marcia
    Timmers, Luis Fernando Saraiva Macedo
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (13) : 4138 - 4146
  • [34] The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2
    Feng, Joy Y.
    Du Pont, Venice
    Babusis, Darius
    Gordon, Calvin J.
    Tchesnokov, Egor P.
    Perry, Jason K.
    Duong, Vincent
    Vijjapurapu, Arya
    Zhao, Xiaofeng
    Chan, Julie
    Cohen, Cal
    Juneja, Kavita
    Cihlar, Tomas
    Gotte, Matthias
    Bilello, John P.
    MOLECULES, 2022, 27 (13):
  • [35] Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors
    Ullrich, Sven
    Sasi, Vishnu M.
    Mahawaththa, Mithun C.
    Ekanayake, Kasuni B.
    Morewood, Richard
    George, Josemon
    Shuttleworth, Laura
    Zhang, Xiaobai
    Whitefield, Cassidy
    Otting, Gottfried
    Jackson, Colin
    Nitsche, Christoph
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 50
  • [36] Synthesis and Virtual Screening of Pyrazolothiazole Conjugates as Promising SARS-CoV-2 Inhibitors
    Seliem, Amal F.
    CHEMISTRYSELECT, 2023, 8 (19):
  • [37] An In silico Investigation to Identify Promising Inhibitors for SARS-CoV-2 Mpro Target
    Alagarsamy, V.
    Sundar, P. Shyam
    Narendhar, B.
    Sulthana, M. T.
    Kulkarni, Vishaka S.
    Aishwarya, A. Dharshini
    Solomon, V. Raja
    Murugesan, S.
    Jubie, S.
    Rohitha, K.
    Dhanwar, Sangeeta
    MEDICINAL CHEMISTRY, 2023, 19 (09) : 925 - 938
  • [38] Interface with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy
    Mueller, Patrick
    Maus, Hannah
    Hammerschmidt, Stefan Josef
    Knaff, Philip
    Mailaender, Volker
    Schirmeister, Tanja
    Kersten, Christian
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (04) : 635 - 665
  • [39] Targeting Viral Ion Channels: A Promising Strategy to Curb SARS-CoV-2
    Singh, Anamika
    Arkin, Isaiah T.
    PHARMACEUTICALS, 2022, 15 (04)
  • [40] A bivalent recombinant vaccine: a promising strategy against both SARS-CoV-2 variants and wild type of the virus
    Wang, Junzhi
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
12345